Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. - Wikidata - wikimedia - TriplyDB

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

http://www.wikidata.org/entity/Q33530824

about

Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library.Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies.Membranous nephropathy: from models to man Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases Experimental Models of Membranous Nephropathy.An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.Anti-phospholipase A2 receptor antibody in membranous nephropathy.Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy Idiopathic membranous nephropathy: an autoimmune disease.Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes.Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease.Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome.Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.Antioxidants in kidney diseases: the impact of bardoxolone methyl.Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.Changing the concepts of immune-mediated glomerular diseases through proteomics.Treatment of idiopathic membranous nephropathy.Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy ChIP-seq analysis of histone H3K9 trimethylation in peripheral blood mononuclear cells of membranous nephropathy patients.Immunohistochemical Glomerular Expression of Phospholipase A2 Receptor in Primary and Secondary Membranous Nephropathy: A Retrospective Study in an Indian Cohort with Clinicopathological Correlations.Management of idiopathic membranous nephropathy.In vivo characterization of renal auto-antigens involved in human auto-immune diseases: the case of membranous glomerulonephritis.Advances in membranous nephropathy: success stories of a long journey.Chronic kidney disease: novel insights from genome-wide association studies.Membranous nephropathy: the start of a paradigm shift.Pathogenesis of membranous nephropathy: recent advances and future challenges.De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?

P2860

Q26747416-3EDF7017-6DE8-4EC2-AFB1-91BBBF1D73A1 Q30596600-D73D3A48-ED90-445E-B00B-96E627599A6C Q31106724-D8F64078-AC32-44B4-A350-99EEB17CEE29 Q33697011-069933EE-C3B1-45E5-A1C0-0F21DE3E6557 Q33872569-94834979-E4A9-4607-ABEE-9723C2ECA1B0 Q34422205-68254857-34F6-4391-AF35-B5FE2B8E6CEF Q34427577-64AB76D3-FA4E-4479-B4D4-3782CF659AC0 Q34591437-30171570-636C-43F5-864E-5BBD4206CDC1 Q34700533-5074D40B-B447-4E1E-97C0-5E96B397A382 Q34701007-E19795C5-2F4C-4F8C-BF78-7395DBB822B3 Q35012441-777940C8-F0D6-497D-8968-D929D5280BE9 Q35030567-B0C8BDFB-8182-4890-9233-DCD9CCE4AE6F Q35142743-1D5423E0-9ED8-404E-9594-7C4EE5CCF6B9 Q35165475-6175ED69-21A0-4821-9B16-5A53B5901C6B Q35422370-D22F82F2-D93C-443F-9176-CCE0AAB4FD17 Q35664105-F610E3D8-09C4-4FF7-A00E-7DDAFE6FD7AC Q35754366-20A06F69-E79D-4CEE-8820-2474B9AC4507 Q35791799-B2C6E569-D6F7-4CD1-88FA-538263780890 Q35799662-10896978-E75D-4326-8008-FC678E2737A7 Q35851046-4EDB5747-FF9F-4E1A-BF63-B5A6C9A9E6EF Q35862682-F01B158C-2A2A-48E4-8A22-FAD966B382D2 Q36026304-9A7FE4D7-DC35-4E9D-BE01-89A0DEDA1B32 Q36063886-0DC62D50-DBF5-4FB5-96B5-A5461D6552D3 Q36199508-8C58F877-3156-4315-932C-219F61131A20 Q36201993-A137C603-FBC1-4B36-9654-03FA644D1EAC Q36280345-A6D953CF-37B0-46F3-AB2F-53425C6DF46C Q36280364-D515C227-3996-4994-87D4-14FEA38AC9BF Q37042246-B538C3C7-4C01-4AEB-8765-0551B1C36AD9 Q37078417-93D488A8-071A-4FBE-9E52-4C79E881F5D3 Q37553082-508B1B11-DD94-4CC3-A05A-09AB25E9390D Q37590239-0D117907-77E0-49C9-8CAD-384A1A10C814 Q37600033-1B34262F-37BE-4483-A76B-7B0420B0CDF7 Q37695117-88BD4601-4B17-423F-A58E-A69E9AE0826A Q37779802-A3AD8888-4C45-455C-9B43-9FFBAFD3700A Q37830008-F50A7B86-6B84-4DB5-B320-F3A6FD6A35D6 Q37851181-C92FFFAC-6FF2-4687-B268-7D3051F38AD4 Q37892304-F83FD13B-21F6-4AFD-8126-61FAE8955921 Q37975360-C628B86F-5D43-49A6-BBEE-57E64883C067 Q37988806-161AE915-3468-45B8-8245-3F8D7451F351 Q38036393-2BDE71FB-CA56-489D-8D4E-E556A73B4EEC

P2860

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

http://www.wikidata.org/entity/Q33530824

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@ast

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@en

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@nl

type

label

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@ast

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@en

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@nl

prefLabel

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@ast

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@en

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@nl

P1433

Q33530824-B7C12798-BEDE-426F-A38B-95E0F56CE401

P1476

Q33530824-04952273-B1E8-404F-BA47-0D5978995CA0

P2093

Q33530824-1118ED55-3FF5-403B-A9CC-467FFA04A16E

Q33530824-2CC39B98-F577-402C-BA76-E793AF9802D3

Q33530824-4B517AAF-1569-4CD0-AF36-5679F4B81632

Q33530824-557E3464-06BF-4D29-B07A-A0ACAA7285B0

Q33530824-779D9D51-608E-4EB3-8C07-0AAF8C31152D

Q33530824-7F504257-C286-4FDB-BAF6-501C45DEE0C2

Q33530824-A016BF9F-995D-4A7C-A51A-78D840F6D333

Q33530824-A1FA2DF6-E0EE-4921-A68E-072E700D360B

Q33530824-B52B5DBB-8BCF-4DE8-A0C2-69981F986E18

Q33530824-B8CA6A40-9534-4CE4-A44D-6A63AAEA66DC

P2860

Q33530824-0556738E-201D-459D-AFCD-8EFF124EDC47

Q33530824-1C03BA26-0172-407B-AB10-25A9DEC4FE12

Q33530824-2213A882-3926-4197-8CF3-C3289BC6A135

Q33530824-251E6605-780D-44C8-AF17-2EAA88928A71

Q33530824-29766E71-64C7-4B78-A0E1-FDAF6B9490F2

Q33530824-3B34A0C0-38CE-4E76-8E93-9F6795499138

Q33530824-415C8DA2-9EBF-46F9-8FEF-2BFC5E70B408

Q33530824-433E03A0-86B7-4786-A07D-88D457105FD6

Q33530824-675B7AB1-75D6-4BCE-9AD3-275F8C10139F

Q33530824-71486A16-871A-467C-96C9-83C3D6D7AF96

P304

Q33530824-7F0F054E-0BE2-4DE4-974B-BB83C81B196C

P31

Q33530824-6053C357-A704-42E8-8451-906418D46C67

P356

Q33530824-C3EDFE72-B253-48B3-8599-40DC0B5AAEBC

P433

Q33530824-643D204C-93EE-44BA-9B5E-106A654B7C87

P478

Q33530824-0E396CA3-A790-440C-B1FD-D1AA0E38C992

P50

Q33530824-634732B6-8F78-4D8B-90E5-3C8FD6311002

Q33530824-6E7841D0-D857-4333-97CC-ED031CE3A8FD

Q33530824-A0383179-E65A-4F95-B91B-08ADC208F2D0

Q33530824-EFE3CFBE-1AF4-4E8B-BCFF-4CEAB9663D7A

Q33530824-F76EED08-37C2-44CD-8DA0-DAA79695A86A

P577

Q33530824-BEB92478-B349-4FFF-8E58-41FCD3AC9245

P698

Q33530824-475F71DC-0507-4F8A-88B9-586F0FE1D6AE

P932

Q33530824-90CAAD4C-B391-4EDC-AD53-3C2308EE1710

P356

P1433

Journal of the American Society of Nephrology

P1476

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

@en

P2093

Alberto Magnasco

http://www.w3.org/2001/XMLSchema#string

Antonella Trivelli

http://www.w3.org/2001/XMLSchema#string

Corrado Murtas

http://www.w3.org/2001/XMLSchema#string

Emilia Corradini

http://www.w3.org/2001/XMLSchema#string

Francesco Scolari

http://www.w3.org/2001/XMLSchema#string

Landino Allegri

http://www.w3.org/2001/XMLSchema#string

Marco Prunotto

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Carnevali

http://www.w3.org/2001/XMLSchema#string

Peter Kador

http://www.w3.org/2001/XMLSchema#string

Rita Gatti

http://www.w3.org/2001/XMLSchema#string

P2860

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells

Developmental expression and function of aldehyde reductase in proximal tubules of the kidney

Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.

Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: a proteomic analysis.

Lipid-lowering therapy in membranous nephropathy.

Membranous glomerulonephritis.

Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.

Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis.

A nephritogenic rat monoclonal antibody to mouse aminopeptidase A. Induction of massive albuminuria after a single intravenous injection

P304

507-519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2008121259

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Bruschi

Giovanni Candiano

Gian Marco Ghiggeri

Andrea Petretto

P577

2010-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20150532

http://www.w3.org/2001/XMLSchema#string

P932

2831859

http://www.w3.org/2001/XMLSchema#string